These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15576968)

  • 1. [Calcium channel blockers and atherosclerosis].
    Hirata K; Yokoyama M
    Clin Calcium; 2004 Jan; 14(1):128-32. PubMed ID: 15576968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers and coronary heart disease.
    Inzitari M; Di Bari M; Marchionni N
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiatherosclerotic hopes of calcium channel blockers].
    Uetake Y; Shimosawa T
    Clin Calcium; 2005 Oct; 15(10):1689-94. PubMed ID: 16199916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers and atherosclerosis.
    Sowers JR
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):3-9. PubMed ID: 2220798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers and stroke.
    Inzitari D; Poggesi A
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers and the prevention of atherosclerosis.
    Gotto AM
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):342S-346S. PubMed ID: 2078321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers and atherosclerosis.
    Henry PD
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S12-5. PubMed ID: 1706008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers.
    Waters D; Lespérance J
    Circulation; 1992 Dec; 86(6 Suppl):III111-6. PubMed ID: 1424044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ca channel blocker and heart failure].
    Kinugawa S; Tsutsui H
    Clin Calcium; 2005 Oct; 15(10):1615-22. PubMed ID: 16199906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events].
    Eleuteri E
    Ital Heart J Suppl; 2001 Jan; 2(1):85-6. PubMed ID: 11216089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of calcium channel blockers in atherosclerosis and cardiovascular event and oxidative vascular damage].
    Fujino T; Sumitomo K; Hasebe N; Kikuchi K
    Clin Calcium; 2004 Jan; 14(1):119-27. PubMed ID: 15576967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atheroma and calcium antagonists].
    Lechat P; Hadjiisky P
    Therapie; 1993; 48 Spec No():665-70. PubMed ID: 8091352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists: current and future applications based on new evidence. Pleiotropic effects of calcium channel blockers on vascular endothelial function].
    Morimoto Y; Kureishi-Bando Y; Murohara T
    Clin Calcium; 2010 Jan; 20(1):69-75. PubMed ID: 20048436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists: current and future applications based on new evidence. Effects of calcium channel blockers on oxidative stress].
    Nishiyama A; Nakano D; Hitomi H
    Clin Calcium; 2010 Jan; 20(1):38-44. PubMed ID: 20048432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine.
    Mason RP; Marche P; Hintze TH
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2155-63. PubMed ID: 14512371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence.
    Mason RP
    Atherosclerosis; 2002 Dec; 165(2):191-9. PubMed ID: 12417269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
    Bangalore S; Parkar S; Messerli FH
    Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modification of coronary arteriosclerosis in man by calcium antagonists?].
    Schneider W; Roebruck P; Cieslinski G; Noack H; Kober G; Alle M; Kaltenbach M
    Z Kardiol; 1991; 80 Suppl 9():63-71. PubMed ID: 1796651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposed synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis.
    Jukema JW; van Boven AJ; Zwinderman AH; Van der Laarse A; Bruschke AV
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():111-8. PubMed ID: 9642484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.